CellWell record HH-88897
Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion
García-Solís P; Alfaro Y; Anguiano B; Delgado G; Guzman RC; Nandi S; Díaz-Muñoz M; Vázquez-Martínez O; Aceves C
Molecular and cellular endocrinology · 2005
In plain language
In Sprague-Dawley rats given N-methyl-N-nitrosourea, continuous molecular iodine cut mammary cancer incidence to 30 percent versus 72.7 percent in controls, alongside higher pendrin and lower lipoperoxidation.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-88897
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.